Literature DB >> 11187414

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

V J Stevens1, E Obarzanek, N R Cook, I M Lee, L J Appel, D Smith West, N C Milas, M Mattfeldt-Beman, L Belden, C Bragg, M Millstone, J Raczynski, A Brewer, B Singh, J Cohen.   

Abstract

BACKGROUND: Weight loss appears to be an effective method for primary prevention of hypertension. However, the long-term effects of weight loss on blood pressure have not been extensively studied.
OBJECTIVE: To present detailed results from the weight loss arm of Trials of Hypertension Prevention (TOHP) II.
DESIGN: Multicenter, randomized dinical trial testing the efficacy of lifestyle interventions for reducing blood pressure over 3 to 4 years. Participants in TOHP II were randomly assigned to one of four groups. This report focuses only on participants assigned to the weight loss (n = 595) and usual care control (n = 596) groups. PATIENTS: Men and women 30 to 54 years of age who had nonmedicated diastolic blood pressure of 83 to 89 mm Hg and systolic blood pressure less than 140 mm Hg and were 110% to 165% of their ideal body weight at baseline. INTERVENTION: The weight loss intervention included a 3-year program of group meetings and individual counseling focused on dietary change, physical activity, and social support MEASUREMENTS: Weight and blood pressure data were collected every 6 months by staff who were blinded to treatment assignment
RESULTS: Mean weight change from baseline in the intervention group was -4.4 kg at 6 months, -2.0 kg at 18 months, and -0.2 kg at 36 months. Mean weight change in the control group at the same time points was 0.1, 0.7, and 1.8 kg. Blood pressure was significantly lower in the intervention group than in the control group at 6, 18, and 36 months. The risk ratio for hypertension in the intervention group was 0.58 (95% CI, 0.36 to 0.94) at 6 months, 0.78 (CI, 0.62 to 1.00) at 18 months, and 0.81 (CI, 0.70 to 0.95) at 36 months. In subgroup analyses, intervention participants who lost at least 4.5 kg at 6 months and maintained this weight reduction for the next 30 months had the greatest reduction in blood pressure and a relative risk for hypertension of 0.35 (CI, 0.20 to 0.59).
CONCLUSIONS: Clinically significant long-term reductions in blood pressure and reduced risk for hypertension can be achieved with even modest weight loss.

Entities:  

Mesh:

Year:  2001        PMID: 11187414     DOI: 10.7326/0003-4819-134-1-200101020-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  265 in total

Review 1.  Quality of life with nonpharmacologic treatment of hypertension.

Authors:  J P Roel; C L Hildebrant; R H Grimm
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

Review 2.  Prehypertension: a meta-analysis of the epidemiology, risk factors, and predictors of progression.

Authors:  Xiaofan Guo; Liling Zou; Xingang Zhang; Jue Li; Liqiang Zheng; Zhaoqing Sun; Jian Hu; Nathan D Wong; Yingxian Sun
Journal:  Tex Heart Inst J       Date:  2011

3.  Potential national and state medical care savings from primary disease prevention.

Authors:  Barbara A Ormond; Brenda C Spillman; Timothy A Waidmann; Kyle J Caswell; Bogdan Tereshchenko
Journal:  Am J Public Health       Date:  2010-11-18       Impact factor: 9.308

Review 4.  Glycemic control and weight reduction without causing hypoglycemia: the case for continued safe aggressive care of patients with type 2 diabetes mellitus and avoidance of therapeutic inertia.

Authors:  Stanley S Schwartz; Benjamin A Kohl
Journal:  Mayo Clin Proc       Date:  2010-11-24       Impact factor: 7.616

5.  Prevalence rates of hypertension self-care activities among African Americans.

Authors:  Jan Warren-Findlow; Rachel B Seymour
Journal:  J Natl Med Assoc       Date:  2011-06       Impact factor: 1.798

6.  Family functioning and weight loss in a sample of african americans and whites.

Authors:  Carmen D Samuel-Hodge; Ziya Gizlice; Jianwen Cai; Phillip J Brantley; Jamy D Ard; Laura P Svetkey
Journal:  Ann Behav Med       Date:  2010-12

7.  Weight loss to treat urinary incontinence in overweight and obese women.

Authors:  Leslee L Subak; Rena Wing; Delia Smith West; Frank Franklin; Eric Vittinghoff; Jennifer M Creasman; Holly E Richter; Deborah Myers; Kathryn L Burgio; Amy A Gorin; Judith Macer; John W Kusek; Deborah Grady
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

8.  Experimental Weight Gain Increases Ambulatory Blood Pressure in Healthy Subjects: Implications of Visceral Fat Accumulation.

Authors:  Naima Covassin; Fatima H Sert-Kuniyoshi; Prachi Singh; Abel Romero-Corral; Diane E Davison; Francisco Lopez-Jimenez; Michael D Jensen; Virend K Somers
Journal:  Mayo Clin Proc       Date:  2018-05       Impact factor: 7.616

9.  Prevalence of undiagnosed and inadequately treated type 2 diabetes mellitus, hypertension, and dyslipidemia in morbidly obese patients who present for bariatric surgery.

Authors:  Rouzbeh Mostaedi; Denise E Lackey; Sean H Adams; Stephen A Dada; Zahid A Hoda; Mohamed R Ali
Journal:  Obes Surg       Date:  2014-06       Impact factor: 4.129

Review 10.  Hypercortisolism in obesity-associated hypertension.

Authors:  Amy G Varughese; Oksana Nimkevych; Gabriel I Uwaifo
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.